38.01
Schlusskurs vom Vortag:
$39.14
Offen:
$39.14
24-Stunden-Volumen:
103.24K
Relative Volume:
0.17
Marktkapitalisierung:
$1.92B
Einnahmen:
$249.12M
Nettoeinkommen (Verlust:
$7.11M
KGV:
305.02
EPS:
0.1246
Netto-Cashflow:
$-8.30M
1W Leistung:
+1.70%
1M Leistung:
+1.75%
6M Leistung:
-5.74%
1J Leistung:
-33.76%
Vericel Corp Stock (VCEL) Company Profile
Firmenname
Vericel Corp
Sektor
Branche
Telefon
(734) 930-5555
Adresse
64 SIDNEY ST., CAMBRIDGE, MA
Vergleichen Sie VCEL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
VCEL
Vericel Corp
|
37.99 | 1.98B | 249.12M | 7.11M | -8.30M | 0.1246 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.63 | 118.58B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
749.34 | 79.40B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
811.57 | 51.18B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
360.84 | 48.88B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
339.19 | 37.49B | 4.98B | 69.59M | 525.67M | 0.5197 |
Vericel Corp Stock (VCEL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-17 | Herabstufung | BTIG Research | Buy → Neutral |
| 2024-08-09 | Eingeleitet | Canaccord Genuity | Buy |
| 2024-06-20 | Eingeleitet | TD Cowen | Buy |
| 2024-01-25 | Hochstufung | Truist | Hold → Buy |
| 2023-08-08 | Hochstufung | BTIG Research | Neutral → Buy |
| 2022-11-10 | Herabstufung | BTIG Research | Buy → Neutral |
| 2022-11-09 | Herabstufung | Truist | Buy → Hold |
| 2022-10-14 | Fortgesetzt | Stephens | Overweight |
| 2021-01-11 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2020-12-18 | Eingeleitet | Stephens | Overweight |
| 2020-09-17 | Eingeleitet | Truist | Buy |
| 2019-10-09 | Eingeleitet | H.C. Wainwright | Buy |
| 2019-02-28 | Herabstufung | Needham | Buy → Hold |
| 2018-08-08 | Bestätigt | Needham | Buy |
| 2018-07-16 | Hochstufung | Ladenburg Thalmann | Neutral → Buy |
| 2018-04-04 | Eingeleitet | Leerink Partners | Outperform |
| 2018-03-06 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2018-03-06 | Bestätigt | Needham | Buy |
| 2018-03-05 | Bestätigt | BTIG Research | Buy |
| 2017-06-21 | Eingeleitet | BTIG Research | Buy |
| 2017-03-13 | Bestätigt | Needham | Buy |
| 2016-12-22 | Eingeleitet | Piper Jaffray | Overweight |
| 2016-11-09 | Bestätigt | Needham | Buy |
| 2016-04-05 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2016-03-11 | Hochstufung | Needham | Hold → Buy |
Alle ansehen
Vericel Corp Aktie (VCEL) Neueste Nachrichten
Cartilage Repair-Cartilage Regeneration Market Covering - openPR.com
Is Vericel Corporation stock heavily shorted2025 Volatility Report & AI Enhanced Trading Alerts - bollywoodhelpline.com
Will Vericel Corporation (ATQP) stock boost dividends furtherJuly 2025 Breakouts & Fast Moving Stock Trade Plans - bollywoodhelpline.com
Vericel Corporation (NASDAQ:VCEL) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World
Vericel (NASDAQ:VCEL) Stock Rating Lowered by Wall Street Zen - Defense World
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Debt-Free Balance Sheet, MACI Momentum, And Burn Care Portfolio Put Vericel On Investors' Radar - RTTNews
Why Is Vericel Stock Gaining Tuesday? - Benzinga
Vericel reports preliminary 2025 revenue of $276 million By Investing.com - Investing.com Canada
Vericel reports preliminary 2025 revenue of $276 million - Investing.com
Vericel Corporation Anticipates $276 Million Total Revenue and 23% Growth in Fourth Quarter Results - Quiver Quantitative
Vericel (NASDAQ: VCEL) shares preliminary 2025 results, updates outlook - Stock Titan
Vericel Announces Preliminary 2025 Financial Results and Business Updates - Yahoo Finance
Vericel Corporation (VCEL) Stock Analysis: Unveiling A 50% Upside In The Biotech Sector - DirectorsTalk Interviews
Summit Creek Advisors LLC Acquires 138,124 Shares of Vericel Corporation $VCEL - MarketBeat
Vericel Corporation $VCEL Shares Sold by Conestoga Capital Advisors LLC - Defense World
How institutional buying supports Vericel Corporation stockJuly 2025 Review & Risk Managed Investment Entry Signals - Улправда
Bond Watch: Why analysts upgrade Vericel Corporation stockFed Meeting & Free Long-Term Investment Growth Plans - Улправда
Why analysts upgrade Vericel Corporation stockCPI Data & Short-Term Trading Opportunity Alerts - Улправда
Shares soar in Vericel after trial shows ixmyelocel-T reduces cardiac events - The Pharma Letter
Vericel Corporation to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026 - Quiver Quantitative
Vericel to Present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026 - Yahoo Finance
VCEL Crosses Above Key Moving Average Level - Nasdaq
Vericel: Growth Plans May Have Run Out Of Gas (Rating Downgrade) - Seeking Alpha
Vericel (NASDAQ:VCEL) Share Price Passes Above 200 Day Moving AverageTime to Sell? - MarketBeat
Vericel (VCEL) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Vericel Corporation (NASDAQ:VCEL) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Will Vericel Corporation (ATQP) stock sustain uptrend momentumStock Watchlist Updates & Free Trading Signals to Sharpen Your Edge - bollywoodhelpline.com
How Investors Are Reacting To Vericel (VCEL) Reaffirmed Guidance And MACI-Focused Growth Narrative - simplywall.st
Truist Slashes PT on Vericel Corporation (VCEL) to $45 From $50 - Insider Monkey
Congress Asset Management Co. Lowers Stake in Vericel Corporation $VCEL - MarketBeat
Vericel price target lowered to $45 from $50 at Truist - MSN
VCEL (Vericel) EV-to-OCF : 30.39 (As of Dec. 19, 2025) - GuruFocus
How Vericel Corporation stock reacts to inflationary pressures2025 Valuation Update & Weekly Market Pulse Updates - DonanımHaber
Why Vericel Corporation stock could see breakout soonMarket Volume Report & Long-Term Safe Investment Plans - DonanımHaber
Vericel (VCEL) Sees Target Price Lowered by Truist Securities | - GuruFocus
VCEL FinancialsIncome Statement - Quiver Quantitative
Here's Why We Think Vericel (NASDAQ:VCEL) Might Deserve Your Attention Today - Yahoo Finance
Institutional Investors Accumulate Vericel Shares Amid Positive Earnings Shift - AD HOC NEWS
Vericel Corp (VCEL) CHRO receives 2,625 shares from RSU vesting on 07/22/2025 - Stock Titan
Osterweis Capital Management Inc. Takes $9.71 Million Position in Vericel Corporation $VCEL - MarketBeat
Next Century Growth Investors LLC Has $28.45 Million Stock Position in Vericel Corporation $VCEL - MarketBeat
How Vericel’s Q3 Beat and MACI Arthro Momentum Could Shape Vericel (VCEL) Investors’ Outlook - simplywall.st
Russell Investments Group Ltd. Purchases 32,976 Shares of Vericel Corporation $VCEL - MarketBeat
Is Vericel’s Recent Pullback a Chance or a Warning for Investors in 2025? - simplywall.st
Vericel (VCEL) director Wotton sells $189500 in stock - Investing.com India
Director’s Big Move: Vericel Stock Sale Shakes Up the Market! - TipRanks
Insider Sell: Paul Wotton Sells 5,000 Shares of Vericel Corp (VC - GuruFocus
Vericel’s chief medical officer sells $64,659 in VCEL stock By Investing.com - Investing.com South Africa
Vericel (VCEL) director Wotton sells $189500 in stock By Investing.com - Investing.com South Africa
Vericel’s chief medical officer sells $64,659 in VCEL stock - Investing.com India
Finanzdaten der Vericel Corp-Aktie (VCEL)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):